ISPOR 2020 has been canceled due to current status of the COVID-19 pandemic. Learn More

Exhibits

ISPOR 2020 — Orlando, FL, USA — HEOR: Advancing Evidence to Action

As a Society committed to improving health and as a global event producer, ISPOR has been closely monitoring news and reports of coronavirus disease (COVID-19) outbreaks globally. The current status of the pandemic and associated governmental regulations, restrictions, and advisories necessarily requires ISPOR to cancel its upcoming annual, international conference, ISPOR 2020, that was scheduled for May 16-20 in Orlando, FL, USA. Guidance informing this decision includes the US Centers for Disease Control and Prevention recent announcement advising against the organization of group meetings of more than 50 persons anywhere in the United States during the next 8 weeks, the US Federal Government and Florida States of Emergency and a growing number of mandated restrictions on business activities and gatherings of individuals, multiple travel restrictions enacted by governments and businesses, and the high likelihood that the number of cases of COVID-19 and related restrictions will continue to grow in the coming weeks and months.

While ISPOR is disappointed to announce the decision to cancel this event, we know that there is no other option and that it is the right one for our registrants, members, ISPOR, and for society at large. ISPOR is thoroughly committed to its mission and to serving its members and the broader healthcare audience, especially during the extraordinary global healthcare crisis that COVID-19 presents. The Society will be announcing online programming on high-priority health economics and outcomes research topics, over the next few weeks.

For additional information on ISPOR 2020 for current registrants, exhibitors, and presenters etc, please view the “Cancellation Information” page for additional details.

As of today, all other 2020 ISPOR conferences are proceeding as planned and updates will be provided if and as the situation changes. Additional information on COVID-19 can be found at:

World Health Organization—Advice for the Public

US Centers for Disease Control and Prevention—Coronavirus Disease

European Centre for Disease Prevention and Control—COVID-19

ISPOR is continuing to closely monitor news and reports of COVID-19 outbreaks globally and will plan to announce potential changes to future conferences if needed. The Society has an active crisis preparedness team and plan for COVID-19. This team is actively monitoring the situation globally, meeting on a routine basis with key stakeholders, and contingency planning in the event any changes to future conferences are needed. Please know that the Society’s conference decision making and management are founded on a strong commitment to global health, as well as the health and well-being of its members and conference attendees.

Thank you to our ISPOR 2020 Exhibitors!

Adelphi Real World & Adelphi Values 115
Aetion 811
Analysis Group201
AplusA 
908
Barrington James 821
BHE215
Boston Strategic Partners, Inc. 206
Cardinal Health501
Certara Evidence & Access*801
Clark Davis Associates Table 4  
Clinical Ink 109
Costello Medical 302
Covance Market Access 121
Creativ-Ceutical 123
CTI Clinical Trial and Consulting Services 101
Cytel 707
Decisions Resources Group 321
EPI-Q, Inc. 107
Eversana125
Evidence Partners, Inc 221
Evidera*507
Evidinno Outcomes Research Inc. 225
Express Scripts 602
FACIT.org/FACITtrans1002
FIECON 1010
GENESIS RESEARCH423
HealthCore*601
HOPE Rutgers University Table 3
Hunnect Ltd. 209
IBM Watson Health 307
ICON Clinical Research 200
InterSytems Corporation 525
IQVIA301
ISPOR409
JMDC, Inc. Table 7
Kantar*515
KMK Consulting Inc. Table 5
Mapi Research Trust 203
Market Access Transformation 721
McKesson 421
Medical Data Vision Co, Ltd. 223
Medidata, a Dassault Systèmes company621
Merck 1022
Monument Analytics 623
Novosys Health1020
OBERD729
OM1715
Optum 609
PAREXEL111
PHAR521
Pharmerit International* 315
PicnicHealth816
Policy Analysis Inc. 325
PRA Health Sciences 1014
Precision Xtract 725
Premier, Inc. 329
PRMA Consulting 211
Purple Squirrel Economics  717
Rare Patient Voice 208
RTI Health Solutions* 701
RWS Life Sciences 809
SAS Institute Inc. 216
STATinMED Research 322
The Evidence Base 308
TreeAge Software, Inc. 117
TriNetX1000
Tufts Medical Center 622
University of Florida Table 6 
University of Maryland- Pharmaceutical Health Services Research Graduate ProgramTable 2
Value Analytics Labs*503
Veradigm*815
Xavier University Table 1
Xcenda 401
ZS430

*Island exhibitors are identified in bold. Sponsors are identified in bold and with an asterisk.